Revenue declined 15% year-over-year to $210.5 million, with net loss improving to $127.9 million due to lower impairment charges. Paying users fell 16%, but ARPPU rose slightly. Q3 2026 guidance projects revenue of $205–$213 million and Adjusted EBITDA of $56–$60 million.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.